General MedicationsORALStandard
LEVOFLOXACIN
LEVOFLOXACIN
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LEVOFLOXACIN is listed in Drugs@FDA under application 204968 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOFLOXACIN Form and strength TABLET;ORAL - 250MG Sponsor HEC PHARM Submission history Latest submission status date: 2024-09-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVOFLOXACIN is listed in Drugs@FDA under application 204968 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOFLOXACIN Form and strength TABLET;ORAL - 250MG Sponsor HEC PHARM Submission history Latest submission status date: 2024-09-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.